The world’s first high-throughput automated sample transfer processing system, MGISTP-7000, received Class I medical device qualification by the China National Medical Product Administration (NMPA) on August 7, 2020, allowing it to enter the Chinese market. It also received the EU CE marking on August 14, 2020, which means the product has been approved to enter the EU market. MGISTP-7000 is our high-throughput automated sample transfer processing system, which integrates tube uncapping,...

In this global epidemic, a group of unknown people who brave the winds and waves to support the global pandemic response. They are the support team of MGI who worked day and night to help with the installation, debug and training of equipments, so as to ensure that all of the equipments can be put into use in time, and provide powerful support and guarantee for overseas epidemic prevention and control. Today, let us together hear about the story of our oversea colleague, Riddhi Patel, who...

Figure 1. Cleavage levels at putative genomic off-target loci containing fewer than five mismatches (white cells) for cbptargets 1, 4, and 5 were analyzed by deep sequencing. Tip 1 Featured papers published with data from MGISEQ-200 (DNBSEQ-G50) DOI: 10.13217/j.scjpm.2019.0481 DOI: 10.1126/sciadv.aay6687 DOI: 10.1016/j.cell.2020.04.011 Remark: DNBSEQ-G50 retains its original product name MGISEQ-200 in China and certain overseas markets.

MGI respects the court's ruling on Illumina's request for a preliminary injunction, but we do not agree with this decision and we are evaluating our options including an immediate appeal of this ruling. MGI also looks forward to the final decision on this matter after a full trial on the merits has occurred. In the meantime, the results of this judgment will not affect MGI ’s business operations outside the United States. As a leader in the gene sequencing equipment industry, MGI is winning ...

As a result of the outbreak of COVID-19, this year's 53rd European Congress of Human Genetics (ESHG 2020) was held online. MGI CSO Dr. Rade Drmanac, Dr. Nik Matthews of Institute of Cancer Research, UK, Prof Miguel Esteban at the Chinese Academy of Sciences Guangzhou Institute of Biomedicine and Health, and Prof. Lars Engstrand of Karolinska Institute & Science for Life Laboratory in Sweden shared the latest progress of high-throughput sequencing technologies and valuable experience of utilizin...

MGISEQ-200 Used to Confirm Suspected Cases of COVID-19 "The MGISEQ-200 DNBSEQ platform helped us to fight against COVID-19 in terms of ultra-high sensitivity detection of complex infections, virus mutation monitoring, tracing, pathogenesis, prediction, and assistance in clinical treatment." ——Bamrasnaradura Infectious Diseases Institute, Department of Disease Control, Thailand In Thailand the rapid and effective development of epidemic prevention and control work has helped to keep the cumu...